Recordati is an Italian pharmaceutical group whose rare-disease arm markets oncology and haematology products in Europe, including siltuximab (Sylvant), chlormethine gel (Ledaga) and dinutuximab beta (Qarziba).
Recordati, based in Milan and listed as REC.MI, is an Italian pharmaceutical group whose rare disease arm markets oncology and haematology products in Europe, including siltuximab, sold as Sylvant, chlormethine gel, sold as Ledaga, and dinutuximab beta, sold as Qarziba. Recordati Rare Diseases acquired EUSA Pharma in 2022, adding Sylvant for multicentric Castleman disease, Qarziba for high-risk neuroblastoma and Fotivda, or tivozanib, in Europe, alongside Ledaga licensed from Helsinn. OnCo links it to siltuximab and mechlorethamine. Whether a rare disease marketer can keep paediatric and ultra-rare oncology products available across Europe at prices health systems accept is the open question. Siltuximab has its own page.
The first antibiotic used as an anticancer drug (1954) and still the core of chemotherapy for Wilms tumour, rhabdomyosarcoma and gestational trophoblastic disease.
Mechlorethamine, or nitrogen mustard, was the first chemotherapy ever used, in 1940s Hodgkin lymphoma. Today its main use is as a skin gel (Valchlor in the US, Ledaga in Europe) for early cutaneous T-cell lymphoma.
Osilodrostat is a twice-daily tablet that stops the adrenal glands making cortisol. It controls Cushing's disease caused by a pituitary tumour when surgery has failed or is not possible, normalising cortisol in most patients.
Pasireotide is a second-generation somatostatin analogue that hits more receptor types than octreotide. It is approved for Cushing's disease and acromegaly caused by pituitary tumours when surgery has not cured them, at the cost of frequent high blood sugar.
Siltuximab (Sylvant) is an antibody that neutralises the inflammatory messenger interleukin-6. It is the only approved treatment for multicentric Castleman disease, a rare lymph node disorder, in people without HIV or HHV-8 infection.
Shares Helsinn, Mechlorethamine (chlormethine).
Shares Helsinn, Mechlorethamine (chlormethine).
Shares Osilodrostat, Pasireotide.